8-K 1 utahmed8k081004.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 10, 2004 Commission File No. 0-11178 ------- UTAH MEDICAL PRODUCTS, INC. --------------------------- (Exact name of Registrant as specified in its charter) UTAH 87-0342734 ------------------------------- ------------------ (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 7043 South 300 West Midvale, Utah 84047 Address of principal executive offices Registrant's telephone number: (801) 566-1200 -------------- -------------------------------------------------------------------------------- ITEM 5. OTHER EVENTS -------------------------------------------------------------------------------- On August 10, 2004, Utah Medical Products, Inc. issued a press release announcing its response to a Food and Drug Administration Complaint. A copy of the press release is attached hereto as Exhibit 99.1 Consistent with UTMD's long-standing practice of repurchasing its own stock when it believes it is undervalued, the Company also announces that it has been buying and may continue to repurchase its shares in open market transactions. -------------------------------------------------------------------------------- SIGNATURES -------------------------------------------------------------------------------- Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. UTAH MEDICAL PRODUCTS, INC. --------------------------- REGISTRANT Date: 8/10/2004 By: /s/ Kevin L.Cornwell --------------------- --------------------- Kevin L. Cornwell CEO -------------------------------------------------------------------------------- EXHIBIT INDEX Index Number Description ------ ----------- 99.1 Press release issued August 10, 2004: UTMD Responds to Notice of FDA Complaint.